Kaplan-Meier plot of time to antiretroviral treatment initiation for HIV infected rifampicin resistant tuberculosis patients.

Second-line treatment initiation within 6 mo, time to treatment, and site of treatment initiation by age, sex, HIV status, diagnostic facility, and diagnostic test (new rifampicin-resistant tuberculosis patients, 2013 cohort).

Helen Cox (66086)
Lindy Dickson-Hall (3768895)
Norbert Ndjeka (3768898)
Anja van’t Hoog (300467)
Alison Grant (790918)
Frank Cobelens (109566)
Wendy Stevens (62288)
Mark Nicol (3498533)

February 2017

Second-line treatment initiation within 6 mo, time to treatment, and site of treatment initiation...

Time to LFU following initiation of MDR-TB treatment at the Drug Resistant TB Site at Vadodara, Gujarat, India using Kaplan-Meier’s analysis.

Kalpita S. Shringarpure (769247)
Petros Isaakidis (316418)
Karuna D. Sagili (470386)
R. K. Baxi (769248)

July 2015

Time to LFU following initiation of MDR-TB treatment at the Drug Resistant TB Site at Vadodara, G...

Kaplan-Meier survival curve* of the proportion of patients attending public HIV treatment facilities in Brazil (n = 463) between January 1, 1995 and December 31, 2001 who remained TB free at primary study endpoint (i.e., TB, death, or last clinic visit) over the time course (in days) of the study period, by intervention (HAART, ART non-HAART), and non-intervention (ART naïve).

Abraham Miranda (378672)
Meade Morgan (378673)
Leda Jamal (378674)
Kayla Laserson (287607)
Draurio Barreira (328742)
Guida Silva (378675)
Joseney Santos (378676)
Charles Wells (378677)
Patricia Paine (378678)
Denise Garrett (378679)

February 2013

Kaplan-Meier survival curve* of the proportion of patients attending public HIV treatment facilit...

Kaplan-Meier plot of survival during treatment of rifampicin resistant tuberculosis by ART initiation, from multivariate Cox regression analysis for HIV co-infected patients.

Johnny Flippie Daniels (824444)
Mohammed Khogali (550243)
Erika Mohr (3331566)
Vivian Cox (487001)
Sizulu Moyo (23102)
Mary Edginton (305166)
Sven Gudmund Hinderaker (305161)
Graeme Meintjes (221054)
Jennifer Hughes (384435)
Virginia De Azevedo (129372)
Gilles van Cutsem (93995)
Helen Suzanne Cox (824445)

November 2015

Kaplan-Meier plot of survival during treatment of rifampicin resistant tuberculosis by ART initia...

Kaplan-Meier plot for time to tuberculosis in 3942 HIV-infected non-Israeli born citizens, stratified by sex (a). Kaplan-Meier plot for time to tuberculosis in 3942 HIV-infected non-Israeli-born citizens, by period of HIV-diagnosis (b). Kaplan-Meier plot for time to tuberculosis in 3942 HIV-infected non-Israeli-born citizens, by mode of HIV-transmission (c). Kaplan-Meier plot for time to tuberculosis in 3942 HIV-infected non-Israeli-born citizens, by mode of area/country of origin (d). Capitation: The data were retried from the National tuberculosis and HIV/AIDS registries at the Israeli Ministry of Health, Jerusalem, Israel.

Zohar Mor (378648)
Moshe Lidji (488627)
Noa Cedar (488628)
Itamar Grotto (72517)
Daniel Chemtob (488629)

November 2013

Kaplan-Meier plot for time to tuberculosis in 3942 HIV-infected non-Israeli born citizens, strati...

Kaplan-Meier survival plot of time to initial sputum culture conversion by HIV status.

Agumas Shibabaw (5451668)
Baye Gelaw (3181905)
Shu-Hua Wang (4726611)
Belay Tessema (3181893)

June 2018

Kaplan-Meier survival plot of time to initial sputum culture conversion by HIV status.</p

Kaplan-Meier curve for time from start of TB treatment to ART initiation for before and after service integration in Town 2 clinic from June 2008 to May 2009.

Bernhard Kerschberger (129359)
Katherine Hilderbrand (129362)
Andrew M. Boulle (129364)
David Coetzee (129367)
Eric Goemaere (129370)
Virginia De Azevedo (129372)
Gilles Van Cutsem (2589493)

October 2012

Kaplan-Meier curve for time from start of TB treatment to ART initiation for before and after ser...

Kaplan-Meier plot of linkage-to-care by time since newly diagnosed HIV-positive, by study arm.

Liesl Page-Shipp (288202)
James J. Lewis (143313)
Kavindhran Velen (412301)
Sedikanelo Senoge (4907293)
Elizabeth Zishiri (4907287)
Flora Popane (583232)
Violet N. Chihota (143307)
Dave Clark (4907290)
Gavin J. Churchyard (143332)
Salome Charalambous (321319)

March 2018

Kaplan-Meier plot of linkage-to-care by time since newly diagnosed HIV-positive, by study arm.</p

Kaplan-Meier survival curve for the impact of lopinavir/ritonavir dosing strategy among patients with HIV/TB coinfection on time until treatment discontinuation.

Richard A. Murphy (304728)
Vincent C. Marconi (220305)
Rajesh T. Gandhi (244028)
Daniel R. Kuritzkes (214840)
Henry Sunpath (298135)

February 2013

Kaplan-Meier survival curve for the impact of lopinavir/ritonavir dosing strategy among patients ...

Kaplan-Meier curve of time to TB for persons diagnosed with incident TB by 96 weeks post-ART initiation.

Mark W. Tenforde (696350)
Nikhil Gupte (189999)
David W. Dowdy (346488)
David M. Asmuth (696351)
Ashwin Balagopal (19837)
Richard B. Pollard (310136)
Patcharaphan Sugandhavesa (584460)
Javier R. Lama (116213)
Sandy Pillay (696352)
Sandra W. Cardoso (546770)
Jyoti Pawar (696353)
Breno Santos (504115)
Cynthia Riviere (143755)
Noluthando Mwelase (696354)
Cecilia Kanyama (504116)
Johnstone Kumwenda (143748)
James G. Hakim (583384)
Nagalingeswaran Kumarasamy (36007)
Robert Bollinger (375260)
Richard D. Semba (350363)
Thomas B. Campbell (143725)
Amita Gupta (21762)

February 2015

Kaplan-Meier curve of time to TB for persons diagnosed with incident TB by 96 weeks post-ART init...

For previously diagnosed rifampicin-resistant tuberculosis patients, time from first recorded rifampicin-resistant tuberculosis diagnosis, HIV status, treatment initiation, and time to treatment by previous second-line treatment status (not weighted for sampling method).

Helen Cox (66086)
Lindy Dickson-Hall (3768895)
Norbert Ndjeka (3768898)
Anja van’t Hoog (300467)
Alison Grant (790918)
Frank Cobelens (109566)
Wendy Stevens (62288)
Mark Nicol (3498533)

February 2017

For previously diagnosed rifampicin-resistant tuberculosis patients, time from first recorded rif...

Kaplan Meier curves for time to the development of ADRs among HIV patients on ART, Felege Hiwot Referral hospital, 2011–2016 classified by WHO clinical stage.

Etsegenet Kindie (4710129)
Zelalem Alamrew Anteneh (4710130)
Endalkachew Worku (4710128)

December 2017

Kaplan Meier curves for time to the development of ADRs among HIV patients on ART, Felege Hiwot R...

Cumulative Time-to-event Plots by Algorithm.

Pren Naidoo (606701)
Elizabeth du Toit (465823)
Rory Dunbar (305942)
Carl Lombard (17685)
Judy Caldwell (342298)
Anne Detjen (606702)
S. Bertel Squire (308149)
Donald A. Enarson (257339)
Nulda Beyers (305944)

July 2014

Kaplan Meier time-to-event plots are shown for MDR-TB treatment commencement time (sample taken t...

Time to TB treatment in 114 TB cases, by basis of TB treatment initiation.

Colleen F. Hanrahan (296075)
Katerina Selibas (418747)
Christopher B. Deery (418748)
Heather Dansey (418749)
Kate Clouse (418750)
Jean Bassett (418751)
Lesley Scott (144110)
Wendy Stevens (62288)
Ian Sanne (170641)
Annelies Van Rie (36715)

June 2013

Kaplan-Meier curves showing time to treatment stratified by basis of TB diagnosis, excluding thos...

Kaplan-Meier curve of HIV-infected patients who developed active tuberculosis disease by interferon-gamma release assay (IGRA) status, excluding 31 subjects with indeterminate results (N = 741).

Susan Shin-Jung Lee (784202)
Hsi-Hsun Lin (473561)
Hung-Chin Tsai (673178)
Ih-Jen Su (87501)
Chin-Hui Yang (450823)
Hsin-Yun Sun (61134)
Chien-Chin Hung (784203)
Cheng-Len Sy (784204)
Kuan-Sheng Wu (784205)
Jui-Kuang Chen (784206)
Yao-Shen Chen (139714)
Chi-Tai Fang (125570)

August 2015

Kaplan-Meier curve of HIV-infected patients who developed active tuberculosis disease by interfer...

Second-line treatment initiation within 6 mo, time to treatment, and site of treatment initiation by age, sex, HIV status, diagnostic facility, and diagnostic test (new rifampicin-resistant tuberculosis patients, 2013 cohort).

Helen Cox (66086)
Lindy Dickson-Hall (3768895)
Norbert Ndjeka (3768898)
Anja van’t Hoog (300467)
Alison Grant (790918)
Frank Cobelens (109566)
Wendy Stevens (62288)
Mark Nicol (3498533)

February 2017

Second-line treatment initiation within 6 mo, time to treatment, and site of treatment initiation...

Time to LFU following initiation of MDR-TB treatment at the Drug Resistant TB Site at Vadodara, Gujarat, India using Kaplan-Meier’s analysis.

Kalpita S. Shringarpure (769247)
Petros Isaakidis (316418)
Karuna D. Sagili (470386)
R. K. Baxi (769248)

July 2015

Time to LFU following initiation of MDR-TB treatment at the Drug Resistant TB Site at Vadodara, G...

Kaplan-Meier survival curve* of the proportion of patients attending public HIV treatment facilities in Brazil (n = 463) between January 1, 1995 and December 31, 2001 who remained TB free at primary study endpoint (i.e., TB, death, or last clinic visit) over the time course (in days) of the study period, by intervention (HAART, ART non-HAART), and non-intervention (ART naïve).

Abraham Miranda (378672)
Meade Morgan (378673)
Leda Jamal (378674)
Kayla Laserson (287607)
Draurio Barreira (328742)
Guida Silva (378675)
Joseney Santos (378676)
Charles Wells (378677)
Patricia Paine (378678)
Denise Garrett (378679)

February 2013

Kaplan-Meier survival curve* of the proportion of patients attending public HIV treatment facilit...

Kaplan-Meier plot of survival during treatment of rifampicin resistant tuberculosis by ART initiation, from multivariate Cox regression analysis for HIV co-infected patients.

Johnny Flippie Daniels (824444)
Mohammed Khogali (550243)
Erika Mohr (3331566)
Vivian Cox (487001)
Sizulu Moyo (23102)
Mary Edginton (305166)
Sven Gudmund Hinderaker (305161)
Graeme Meintjes (221054)
Jennifer Hughes (384435)
Virginia De Azevedo (129372)
Gilles van Cutsem (93995)
Helen Suzanne Cox (824445)

November 2015

Kaplan-Meier plot of survival during treatment of rifampicin resistant tuberculosis by ART initia...

Kaplan-Meier plot for time to tuberculosis in 3942 HIV-infected non-Israeli born citizens, stratified by sex (a). Kaplan-Meier plot for time to tuberculosis in 3942 HIV-infected non-Israeli-born citizens, by period of HIV-diagnosis (b). Kaplan-Meier plot for time to tuberculosis in 3942 HIV-infected non-Israeli-born citizens, by mode of HIV-transmission (c). Kaplan-Meier plot for time to tuberculosis in 3942 HIV-infected non-Israeli-born citizens, by mode of area/country of origin (d). Capitation: The data were retried from the National tuberculosis and HIV/AIDS registries at the Israeli Ministry of Health, Jerusalem, Israel.

Zohar Mor (378648)
Moshe Lidji (488627)
Noa Cedar (488628)
Itamar Grotto (72517)
Daniel Chemtob (488629)

November 2013

Kaplan-Meier plot for time to tuberculosis in 3942 HIV-infected non-Israeli born citizens, strati...

Kaplan-Meier survival plot of time to initial sputum culture conversion by HIV status.

Agumas Shibabaw (5451668)
Baye Gelaw (3181905)
Shu-Hua Wang (4726611)
Belay Tessema (3181893)

June 2018

Kaplan-Meier survival plot of time to initial sputum culture conversion by HIV status.</p

Kaplan-Meier curve for time from start of TB treatment to ART initiation for before and after service integration in Town 2 clinic from June 2008 to May 2009.

Bernhard Kerschberger (129359)
Katherine Hilderbrand (129362)
Andrew M. Boulle (129364)
David Coetzee (129367)
Eric Goemaere (129370)
Virginia De Azevedo (129372)
Gilles Van Cutsem (2589493)

October 2012

Kaplan-Meier curve for time from start of TB treatment to ART initiation for before and after ser...

Kaplan-Meier plot of linkage-to-care by time since newly diagnosed HIV-positive, by study arm.

Liesl Page-Shipp (288202)
James J. Lewis (143313)
Kavindhran Velen (412301)
Sedikanelo Senoge (4907293)
Elizabeth Zishiri (4907287)
Flora Popane (583232)
Violet N. Chihota (143307)
Dave Clark (4907290)
Gavin J. Churchyard (143332)
Salome Charalambous (321319)

March 2018

Kaplan-Meier plot of linkage-to-care by time since newly diagnosed HIV-positive, by study arm.</p

Kaplan-Meier survival curve for the impact of lopinavir/ritonavir dosing strategy among patients with HIV/TB coinfection on time until treatment discontinuation.

Richard A. Murphy (304728)
Vincent C. Marconi (220305)
Rajesh T. Gandhi (244028)
Daniel R. Kuritzkes (214840)
Henry Sunpath (298135)

February 2013

Kaplan-Meier survival curve for the impact of lopinavir/ritonavir dosing strategy among patients ...

Kaplan-Meier curve of time to TB for persons diagnosed with incident TB by 96 weeks post-ART initiation.

Mark W. Tenforde (696350)
Nikhil Gupte (189999)
David W. Dowdy (346488)
David M. Asmuth (696351)
Ashwin Balagopal (19837)
Richard B. Pollard (310136)
Patcharaphan Sugandhavesa (584460)
Javier R. Lama (116213)
Sandy Pillay (696352)
Sandra W. Cardoso (546770)
Jyoti Pawar (696353)
Breno Santos (504115)
Cynthia Riviere (143755)
Noluthando Mwelase (696354)
Cecilia Kanyama (504116)
Johnstone Kumwenda (143748)
James G. Hakim (583384)
Nagalingeswaran Kumarasamy (36007)
Robert Bollinger (375260)
Richard D. Semba (350363)
Thomas B. Campbell (143725)
Amita Gupta (21762)

February 2015

Kaplan-Meier curve of time to TB for persons diagnosed with incident TB by 96 weeks post-ART init...

For previously diagnosed rifampicin-resistant tuberculosis patients, time from first recorded rifampicin-resistant tuberculosis diagnosis, HIV status, treatment initiation, and time to treatment by previous second-line treatment status (not weighted for sampling method).

Helen Cox (66086)
Lindy Dickson-Hall (3768895)
Norbert Ndjeka (3768898)
Anja van’t Hoog (300467)
Alison Grant (790918)
Frank Cobelens (109566)
Wendy Stevens (62288)
Mark Nicol (3498533)

February 2017

For previously diagnosed rifampicin-resistant tuberculosis patients, time from first recorded rif...

Kaplan Meier curves for time to the development of ADRs among HIV patients on ART, Felege Hiwot Referral hospital, 2011–2016 classified by WHO clinical stage.

Etsegenet Kindie (4710129)
Zelalem Alamrew Anteneh (4710130)
Endalkachew Worku (4710128)

December 2017

Kaplan Meier curves for time to the development of ADRs among HIV patients on ART, Felege Hiwot R...

Cumulative Time-to-event Plots by Algorithm.

Pren Naidoo (606701)
Elizabeth du Toit (465823)
Rory Dunbar (305942)
Carl Lombard (17685)
Judy Caldwell (342298)
Anne Detjen (606702)
S. Bertel Squire (308149)
Donald A. Enarson (257339)
Nulda Beyers (305944)

July 2014

Kaplan Meier time-to-event plots are shown for MDR-TB treatment commencement time (sample taken t...

Time to TB treatment in 114 TB cases, by basis of TB treatment initiation.

Colleen F. Hanrahan (296075)
Katerina Selibas (418747)
Christopher B. Deery (418748)
Heather Dansey (418749)
Kate Clouse (418750)
Jean Bassett (418751)
Lesley Scott (144110)
Wendy Stevens (62288)
Ian Sanne (170641)
Annelies Van Rie (36715)

June 2013

Kaplan-Meier curves showing time to treatment stratified by basis of TB diagnosis, excluding thos...

Kaplan-Meier curve of HIV-infected patients who developed active tuberculosis disease by interferon-gamma release assay (IGRA) status, excluding 31 subjects with indeterminate results (N = 741).

Susan Shin-Jung Lee (784202)
Hsi-Hsun Lin (473561)
Hung-Chin Tsai (673178)
Ih-Jen Su (87501)
Chin-Hui Yang (450823)
Hsin-Yun Sun (61134)
Chien-Chin Hung (784203)
Cheng-Len Sy (784204)
Kuan-Sheng Wu (784205)
Jui-Kuang Chen (784206)
Yao-Shen Chen (139714)
Chi-Tai Fang (125570)

August 2015

Kaplan-Meier curve of HIV-infected patients who developed active tuberculosis disease by interfer...

Second-line treatment initiation within 6 mo, time to treatment, and site of treatment initiation by age, sex, HIV status, diagnostic facility, and diagnostic test (new rifampicin-resistant tuberculosis patients, 2013 cohort).

Helen Cox (66086)
Lindy Dickson-Hall (3768895)
Norbert Ndjeka (3768898)
Anja van’t Hoog (300467)
Alison Grant (790918)
Frank Cobelens (109566)
Wendy Stevens (62288)
Mark Nicol (3498533)

February 2017

Second-line treatment initiation within 6 mo, time to treatment, and site of treatment initiation...

Time to LFU following initiation of MDR-TB treatment at the Drug Resistant TB Site at Vadodara, Gujarat, India using Kaplan-Meier’s analysis.

Kalpita S. Shringarpure (769247)
Petros Isaakidis (316418)
Karuna D. Sagili (470386)
R. K. Baxi (769248)

July 2015

Time to LFU following initiation of MDR-TB treatment at the Drug Resistant TB Site at Vadodara, G...

Kaplan-Meier survival curve* of the proportion of patients attending public HIV treatment facilities in Brazil (n = 463) between January 1, 1995 and December 31, 2001 who remained TB free at primary study endpoint (i.e., TB, death, or last clinic visit) over the time course (in days) of the study period, by intervention (HAART, ART non-HAART), and non-intervention (ART naïve).

Abraham Miranda (378672)
Meade Morgan (378673)
Leda Jamal (378674)
Kayla Laserson (287607)
Draurio Barreira (328742)
Guida Silva (378675)
Joseney Santos (378676)
Charles Wells (378677)
Patricia Paine (378678)
Denise Garrett (378679)

February 2013

Kaplan-Meier survival curve* of the proportion of patients attending public HIV treatment facilit...

Kaplan-Meier plot of time to antiretroviral treatment initiation for HIV infected rifampicin resistant tuberculosis patients.

Abstract

Extracted data

Kaplan-Meier plot of time to antiretroviral treatment initiation for HIV infected rifampicin resistant tuberculosis patients.

Abstract

Extracted data

Related items

Related items